Prognostic role of systemic inflammation response index in patients with non-small cell lung cancer: a meta-analysis.

ABSTRACT:

Objectives

The significance of the systemic inflammation response index (SIRI) for predicting prognostic outcomes in patients with non-small cell lung cancer (NSCLC) has been analysed in previous studies, but no consistent conclusions have been obtained. Consequently, the present meta-analysis was performed to identify the significance of SIRI in predicting the prognosis of NSCLC.

Design

This study followed the PRISMA guidelines.

Data sources

PubMed, Web of Science and Embase databases were searched between their inception and 26 November 2023.

Eligibility criteria for selecting studies

Studies investigating the relationship between SIRI and survival outcomes of patients with NSCLC were included.

Data extraction and synthesis

The value of SIRI in predict

SUBMITTER: Ye X 

PROVIDER: S-EPMC11575272 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature